[1]
|
Growth of community‐based immunotherapy treatment in the Veterans Health Administration
Cancer Medicine,
2023
DOI:10.1002/cam4.6372
|
|
|
[2]
|
Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S
The Oncologist,
2021
DOI:10.1002/onco.13721
|
|
|
[3]
|
Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting
Journal of Oncology Practice,
2019
DOI:10.1200/JOP.18.00315
|
|
|
[4]
|
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
Cancer Medicine,
2019
DOI:10.1002/cam4.2268
|
|
|
[5]
|
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
Cancer Medicine,
2019
DOI:10.1002/cam4.2268
|
|
|
[6]
|
Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA
Future Oncology,
2018
DOI:10.2217/fon-2018-0267
|
|
|
[7]
|
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States
BMC Cancer,
2017
DOI:10.1186/s12885-017-3176-x
|
|
|
[8]
|
Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States?
Journal of Medical Economics,
2017
DOI:10.1080/13696998.2017.1384736
|
|
|
[9]
|
Differences in Health Care Use and Costs Among Patients With Cancer Receiving Intravenous Chemotherapy in Physician Offices Versus in Hospital Outpatient Settings
Journal of Oncology Practice,
2017
DOI:10.1200/JOP.2016.012930
|
|
|